EMERGENT BIOSOLUTIONS INC COM STK USD0.001 revenue for the last year amounted to 1.04 B USD, the most of which — 509.80 M USD — came from its highest performing source at the moment, Medical Countermeasures Products, the year earlier bringing 447.20 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought EMERGENT BIOSOLUTIONS INC COM STK USD0.001 822.60 M USD, and the year before that — 607.20 M USD.